Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment
Crossref DOI link: https://doi.org/10.1007/s13318-022-00759-8
Published Online: 2022-03-08
Published Print: 2022-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lin, Swan http://orcid.org/0000-0002-7705-9401
Gong, Jason
Canas, George C.
Winkle, Peter
Pelletier, Kathleen
LaBadie, Robert R.
Ginman, Katherine
Pithavala, Yazdi K.
Text and Data Mining valid from 2022-03-08
Version of Record valid from 2022-03-08
Article History
First Online: 8 March 2022